Jung-Mi Hah, Ph.D. - Publications

Affiliations: 
2002 Northwestern University, Evanston, IL 
Area:
Organic, Synthetic, Bio-Organic, Medicinal Chemistry, Chemical Biology

69 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Im D, Moon H, Kim J, Oh Y, Jang M, Hah JM. Conformational restriction of a type II FMS inhibitor leading to discovery of 5-methyl--(2-aryl-1-benzo[d]imidazo-5-yl)isoxazole-4-carboxamide analogues as selective FLT3 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 34: 1716-1721. PMID 31571509 DOI: 10.1080/14756366.2019.1671837  0.4
2019 Kim J, Choi B, Im D, Jung H, Moon H, Aman W, Hah JM. Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1-pyrazole as highly selective and potent BRAFV600E and CRAF inhibitor. Journal of Enzyme Inhibition and Medicinal Chemistry. 34: 1314-1320. PMID 31307243 DOI: 10.1080/14756366.2019.1599366  0.44
2019 Jung H, Kim J, Im D, Moon H, Hah JM. Design, synthesis, and in vitro evaluation of N-(3-(3-alkyl-1H-pyrazol-5-yl) phenyl)-aryl amide for selective RAF inhibition. Bioorganic & Medicinal Chemistry Letters. PMID 30630714 DOI: 10.1016/j.bmcl.2019.01.003  0.4
2018 Venkanna A, Cho KH, Dhorma LP, Kumar DN, Hah JM, Park HG, Kim SY, Kim MH. Chemistry-oriented synthesis (ChOS) and target deconvolution on neuroprotective effect of a novel scaffold, oxaza spiroquinone. European Journal of Medicinal Chemistry. 163: 453-480. PMID 30530196 DOI: 10.1016/j.ejmech.2018.11.037  0.72
2018 Lee J, Jung H, Kim M, Lee E, Im D, Aman W, Hah JM. Discovery of novel 4-aryl-thieno[1,4]diazepin-2-one derivatives targeting multiple protein kinases as anticancer agents. Bioorganic & Medicinal Chemistry. PMID 29459144 DOI: 10.1016/j.bmc.2018.02.009  0.72
2017 Jung H, Aman W, Hah JM. Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 28372912 DOI: 10.1016/j.bmcl.2017.03.063  0.44
2016 Yang SH, Lee DK, Shin J, Lee S, Baek S, Kim J, Jung H, Hah JM, Kim Y. Nec-1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice. Embo Molecular Medicine. PMID 27861127 DOI: 10.15252/emmm.201606566  0.4
2016 Aman W, Lee J, Kim M, Yang S, Jung H, Hah JM. Discovery of highly selective CRAF inhibitors, 3-carboxamido-2H-indazole-6-arylamide: In silico FBLD design, synthesis and evaluation. Bioorganic & Medicinal Chemistry Letters. PMID 26810260 DOI: 10.1016/j.bmcl.2016.01.037  0.92
2015 Ock CY, Son B, Keam B, Lee SY, Moon J, Kwak H, Kim S, Kim TM, Jeon YK, Kwon SK, Hah JH, Lee SH, Kwon TK, Kim DW, Wu HG, et al. Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. PMID 26677030 DOI: 10.1007/s00432-015-2083-2  0.32
2015 Park Y, Bae SY, Hah JM, Lee SK, Ryu JS. Synthesis of stereochemically diverse cyclic analogs of tubulysins. Bioorganic & Medicinal Chemistry. PMID 26474666 DOI: 10.1016/j.bmc.2015.10.003  0.92
2015 Im D, Jung K, Yang S, Aman W, Hah JM. Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors. European Journal of Medicinal Chemistry. 102: 600-610. PMID 26318067 DOI: 10.1016/j.ejmech.2015.08.031  0.44
2015 Lee DY, Lim JH, Kim YJ, Kim SD, Park SW, Kwon SK, Hah JH, Kwon TK, Kim KH, Kim YH, Sung MW. Effect of Celecoxib on Survival of Mobile Tongue Cancer. Anticancer Research. 35: 4235-41. PMID 26124384  0.36
2015 Kim MH, Lee J, Hah JM. De Novo Design and Synthesis of a γ-Turn Peptidomimetic Scaffold and Its Application as JNK3 Allosteric Ligand. Chemistry, An Asian Journal. 10: 1318-26. PMID 25712695 DOI: 10.1002/asia.201403417  0.72
2015 Park M, Lee YH, Lee SH, Yoo KH, Sung KW, Koo HH, Lee JW, Kang HJ, Park KD, Shin HY, Ahn HS, Lee JW, Chung NG, Cho B, Kim HK, ... ... Hah JO, et al. Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients. Annals of Hematology. 94: 481-9. PMID 25417830 DOI: 10.1007/s00277-014-2222-x  0.52
2015 No JH, Sung MW, Hah JH, Choi SH, Lee MC, Kim HS, Song YS. Prevalence and prognostic value of human papillomavirus genotypes in tonsillar squamous cell carcinoma: a Korean multicenter study. Cancer. 121: 535-44. PMID 25283642 DOI: 10.1002/cncr.29086  0.52
2015 Song JJ, Choi IJ, Chang H, Kim DW, Chang HW, Park GH, Kim MS, Sung MW, Hah JH. Pediatric tracheostomy revisited: a nine-year experience using horizontal intercartilaginous incision. The Laryngoscope. 125: 485-92. PMID 25130887 DOI: 10.1002/lary.24882  0.36
2015 Park SW, Kim JE, Oh SM, Cha WJ, Hah JH, Sung MW. Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species. Head & Neck. 37: 1187-92. PMID 24797795 DOI: 10.1002/hed.23727  0.4
2014 Ock CY, Keam B, Lim Y, Kim TM, Lee SH, Kwon SK, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS. Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience. Head & Neck. PMID 26104823 DOI: 10.1002/hed.23891  0.32
2014 Lee DY, Seok J, Kim YJ, Kim MS, Sung MW, Hah JH. Neck computed tomography in pediatric neck mass as initial evaluation in ED: is it malpractice? The American Journal of Emergency Medicine. 32: 1237-40. PMID 25171800 DOI: 10.1016/j.ajem.2014.07.031  0.36
2014 Kim JE, Lee EK, Lee JM, Bae SH, Choi KH, Lee YH, Hah JO, Choi JH, Kong EJ, Cho IH. Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in children. Korean Journal of Pediatrics. 57: 226-31. PMID 25045365 DOI: 10.3345/kjp.2014.57.5.226  0.52
2014 Song D, Park Y, Yoon J, Aman W, Hah JM, Ryu JS. Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry. 22: 4855-66. PMID 25042560 DOI: 10.1016/j.bmc.2014.06.047  0.44
2014 Park HJ, Park M, Han M, Nam BH, Koh KN, Im HJ, Lee JW, Chung NG, Cho B, Kim HK, Yoo KH, Koo HH, Kang HJ, Shin HY, Ahn HS, ... ... Hah JO, et al. Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT. Bone Marrow Transplantation. 49: 1212-6. PMID 25000455 DOI: 10.1038/bmt.2014.136  0.36
2014 Kim M, Lee J, Jung K, Kim H, Aman W, Ryu JS, Hah JM. Design, synthesis and biological evaluation of benzyl 2-(1H-imidazole-1-yl) pyrimidine analogues as selective and potent Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 3600-4. PMID 24878193 DOI: 10.1016/j.bmcl.2014.05.030  0.72
2014 Park M, Lee YH, Kang HR, Lee JW, Kang HJ, Park KD, Shin HY, Ahn HS, Baek HJ, Kook H, Hwang TJ, Lee JW, Chung NG, Cho B, Kim HK, ... ... Hah JO, et al. Unrelated donor cord blood transplantation for non-malignant disorders in children and adolescents. Pediatric Transplantation. 18: 221-9. PMID 24372660 DOI: 10.1111/petr.12213  0.52
2014 Cha W, Kong IG, Kim H, Hah JH, Sung MW. Desmoid tumor arising from omohyoid muscle: The first report for unusual complication after transaxillary robotic thyroidectomy. Head & Neck. 36: E48-51. PMID 24115367 DOI: 10.1002/hed.23518  0.44
2014 Jung YH, Song CM, Park JH, Kim H, Cha W, Hah JH, Kwon TK, Kim KH, Sung MW. Efficacy of current regular follow-up policy after treatment for head and neck cancer: Need for individualized and obligatory follow-up strategy. Head & Neck. 36: 715-21. PMID 23616261 DOI: 10.1002/hed.23364  0.44
2013 Go SW, Kim BK, Lee SH, Kim TJ, Huh JY, Lee JM, Hah JH, Kim DW, Cho MJ, Kim TW, Kang JY. Successful rechallenge with imatinib in a patient with chronic myeloid leukemia who previously experienced imatinib mesylate induced pneumonitis. Tuberculosis and Respiratory Diseases. 75: 256-9. PMID 24416057 DOI: 10.4046/trd.2013.75.6.256  0.52
2013 Kim MS, Han JW, Jin SS, Lee JM, Hah JH, Kim YJ, Kim SJ, Kang MW, Kang JY. A Case of Mycobacterium kansasii Pulmonary Disease Presenting as Endobronchial Lesions in HIV-Infected Patient. Tuberculosis and Respiratory Diseases. 75: 157-60. PMID 24265644 DOI: 10.4046/trd.2013.75.4.157  0.52
2013 Jeong J, Baek H, Kim YJ, Choi Y, Lee H, Lee E, Kim ES, Hah JH, Kwon TK, Choi IJ, Kwon H. Human salivary gland stem cells ameliorate hyposalivation of radiation-damaged rat salivary glands Experimental and Molecular Medicine. 45. PMID 24232257 DOI: 10.1038/emm.2013.121  0.4
2013 Baek SO, Jang SH, Lee E, Kim S, Hah JO, Park YH, Lee JM, Son SM. CST recovery in pediatric hemiplegic patients: Diffusion tensor tractography study Neuroscience Letters. 557: 79-83. PMID 24176879 DOI: 10.1016/j.neulet.2013.10.047  0.52
2013 Park ES, Jung HL, Kim HJ, Park SS, Bae SH, Shin HY, Song SH, Koh KN, Lyu CJ, Lim YT, Han DK, Hah JO. Hereditary hemolytic anemia in Korea from 2007 to 2011: A study by the Korean Hereditary Hemolytic Anemia Working Party of the Korean Society of Hematology. Blood Research. 48: 211-6. PMID 24086942 DOI: 10.5045/br.2013.48.3.211  0.4
2013 Lim Y, Keam B, Koh Y, Kim TM, Lee SH, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS, Kim KH. Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 116: 55-60. PMID 23570665 DOI: 10.1016/j.oooo.2013.02.007  0.32
2013 Kim MH, Lee J, Jung K, Kim M, Park YJ, Ahn H, Kwon YH, Hah JM. Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects. Bioorganic & Medicinal Chemistry. 21: 2271-85. PMID 23498914 DOI: 10.1016/j.bmc.2013.02.021  0.72
2013 Kim MH, Ryu JS, Hah JM. 3D-QSAR studies of 1,2-diaryl-1H-benzimidazole derivatives as JNK3 inhibitors with protective effects in neuronal cells. Bioorganic & Medicinal Chemistry Letters. 23: 1639-42. PMID 23416008 DOI: 10.1016/j.bmcl.2013.01.082  0.72
2013 Park M, Lee SH, Lee YH, Yoo KH, Sung KW, Koo HH, Kang HJ, Park KD, Shin HY, Ahn HS, Chung NG, Cho B, Kim HK, Koh KN, Im HJ, ... ... Hah JO, et al. Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 640-6. PMID 23380345 DOI: 10.1016/j.bbmt.2013.01.014  0.52
2013 Li F, Park Y, Hah JM, Ryu JS. Synthesis and biological evaluation of 1-(6-methylpyridin-2-yl)-5-(quinoxalin-6-yl)-1,2,3-triazoles as transforming growth factor-β type 1 receptor kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 1083-6. PMID 23294702 DOI: 10.1016/j.bmcl.2012.12.008  0.44
2013 Lee JM, Kim JE, Bae SH, Hah JO. Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma Blood Research. 48: 99-106. DOI: 10.5045/br.2013.48.2.99  0.52
2012 Chung JY, Cho SJ, Cho AE, Hah JM. In silico binding free energy predictability with π-π interaction energy-augmented scoring function: benzimidazole Raf inhibitors as a case study. Bioorganic & Medicinal Chemistry Letters. 22: 3278-83. PMID 22464457 DOI: 10.1016/j.bmcl.2012.03.017  0.36
2012 Kim HJ, Cho HJ, Kim H, El-Gamal MI, Oh CH, Lee SH, Sim T, Hah JM, Yoo KH. New diarylureas and diarylamides possessing acet(benz)amidophenyl scaffold: design, synthesis, and antiproliferative activity against melanoma cell line. Bioorganic & Medicinal Chemistry Letters. 22: 3269-73. PMID 22460030 DOI: 10.1016/j.bmcl.2012.03.020  0.44
2012 Lee JM, Hah JO, Kim HS. The effect of red ginseng extract on inflammatory cytokines after chemotherapy in children Journal of Ginseng Research. 36: 383-390. DOI: 10.5142/jgr.2012.36.4.383  0.52
2012 Ham YJ, Yu H, Kim ND, Hah JM, Selim KB, Choi HG, Sim T. Rhodium-catalyzed reductive cyclization of 1,6-enynes and stereoselective synthesis of the putative structure of lucentamycin A and its stereoisomers Tetrahedron. 68: 1918-1925. DOI: 10.1016/j.tet.2011.12.075  0.92
2011 Kim H, Kim M, Lee J, Yu H, Hah JM. Syntheses of phenylpyrazolodiazepin-7-ones as conformationally rigid analogs of aminopyrazole amide scaffold and their antiproliferative effects on cancer cells. Bioorganic & Medicinal Chemistry. 19: 6760-7. PMID 22014755 DOI: 10.1016/j.bmc.2011.09.042  0.72
2011 Chung JY, Cho SJ, Hah JM. A python-based docking program utilizing a receptor bound ligand shape: PythDock. Archives of Pharmacal Research. 34: 1451-8. PMID 21975806 DOI: 10.1007/s12272-011-0906-5  0.36
2011 Kim MH, Chung JY, Ryu JS, Hah JM. Structure tuning of pyrazolylpyrrole derivatives as ERK inhibitors utilizing dual tools; 3D-QSAR and side-chain hopping. Bioorganic & Medicinal Chemistry Letters. 21: 4900-4. PMID 21775139 DOI: 10.1016/j.bmcl.2011.06.016  0.72
2011 Kim MH, Kim M, Yu H, Kim H, Yoo KH, Sim T, Hah JM. Structure based design and syntheses of amino-1H-pyrazole amide derivatives as selective Raf kinase inhibitors in melanoma cells. Bioorganic & Medicinal Chemistry. 19: 1915-23. PMID 21353571 DOI: 10.1016/j.bmc.2011.01.067  0.72
2011 Jeong DC, Chung NG, Kang HJ, Koo HH, Kook H, Kim SK, Kim SY, Kim HS, Kim HM, Park KD, Park SK, Park JS, Park JE, Park HJ, Park YS, ... ... Hah JO, et al. Epidemiology and clinical long-term outcome of childhood aplastic anemia in Korea for 15 years: retrospective study of the Korean Society of Pediatric Hematology Oncology (KSPHO). Journal of Pediatric Hematology/Oncology. 33: 172-8. PMID 21325968 DOI: 10.1097/MPH.0b013e31820826a8  0.52
2011 Yoo KH, Lee SH, Sung KW, Koo HH, Chung NG, Cho B, Kim HK, Kang HJ, Shin HY, Ahn HS, Baek HJ, Han DK, Kook H, Hwang TJ, Kim SY, ... ... Hah JO, et al. Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases. American Journal of Hematology. 86: 12-7. PMID 21064135 DOI: 10.1002/ajh.21886  0.36
2011 Ahn H, Lee JA, Kim H, Oh CH, Lee SH, Sim T, Hah JM, Kim DJ, Yoo KH. Synthesis and antiproliferative activity of pyridinylcarbonylpyrimidines against melanoma cell line Bulletin of the Korean Chemical Society. 32: 1209-1214. DOI: 10.5012/bkcs.2011.32.4.1209  0.44
2011 Kang SJ, Lee JM, Hah JO, Shim YJ, Lee KS, Shin HJ, Kim HS, Choi EJ, Jeon SE, Lim YT, Park JK, Park ES. Novel influenza a (H1N1) 2009 infection in the pediatric patients with hematologic and oncologic diseases in the Yeungnam region Korean Journal of Pediatrics. 54: 116-121. DOI: 10.3345/kjp.2011.54.3.116  0.52
2010 Lee J, Nam BS, Kim H, Oh CH, Lee SH, Cho SJ, Sim TB, Hah JM, Kim DJ, Tae J, Yoo KH. Synthesis of aminoquinazoline derivatives and their antiproliferative activities against melanoma cell line. Bioorganic & Medicinal Chemistry Letters. 20: 5722-5. PMID 20797858 DOI: 10.1016/j.bmcl.2010.08.010  0.72
2010 Park SW, Kim HS, Hah JW, Jeong WJ, Kim KH, Sung MW. Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines Anti-Cancer Drugs. 21: 823-830. PMID 20717005 DOI: 10.1097/CAD.0b013e32833dada8  0.52
2010 Yu H, Jung Y, Kim H, Lee J, Oh CH, Yoo KH, Sim T, Hah JM. 1,4-dihydropyrazolo[4,3-d]imidazole phenyl derivatives: a novel type II Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 3805-8. PMID 20466542 DOI: 10.1016/j.bmcl.2010.04.039  0.72
2010 Chung JY, Chung HW, Cho SJ, Hah JM, Cho AE. QM/MM based 3D QSAR models for potent B-Raf inhibitors. Journal of Computer-Aided Molecular Design. 24: 385-97. PMID 20358258 DOI: 10.1007/s10822-010-9337-5  0.36
2010 Park SW, Kim HS, Hah JH, Kim KH, Heo DS, Sung MW. Differential effects between cyclooxygenase-2 inhibitors and siRNA on vascular endothelial growth factor production in head and neck squamous cell carcinoma cell lines Head and Neck. 32: 1534-1543. PMID 20222044 DOI: 10.1002/hed.21362  0.52
2010 Lee J, Kim H, Yu H, Chung JY, Oh CH, Yoo KH, Sim T, Hah JM. Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines. Bioorganic & Medicinal Chemistry Letters. 20: 1573-7. PMID 20149658 DOI: 10.1016/j.bmcl.2010.01.064  0.72
2010 Kim HJ, Jung MH, Kim H, El-Gamal MI, Sim TB, Lee SH, Hong JH, Hah JM, Cho JH, Choi JH, Yoo KH, Oh CH. Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma. Bioorganic & Medicinal Chemistry Letters. 20: 413-7. PMID 19897366 DOI: 10.1016/j.bmcl.2009.08.005  0.44
2010 Choi HG, Son JB, Park DS, Ham YJ, Hah JM, Sim T. An efficient and enantioselective total synthesis of naturally occurring L-783277 Tetrahedron Letters. 51: 4942-4946. DOI: 10.1016/j.tetlet.2010.07.122  0.92
2010 Ham YJ, Lee DH, Choi HG, Hah JM, Sim T. The efficient one-step chlorination of methylsulfanyl group on pyrimidine ring system with sulfuryl chloride Tetrahedron Letters. 51: 4609-4611. DOI: 10.1016/j.tetlet.2010.06.056  0.92
2009 Jung MH, Kim H, Choi WK, El-Gamal MI, Park JH, Yoo KH, Sim TB, Lee SH, Baek D, Hah JM, Cho JH, Oh CH. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line. Bioorganic & Medicinal Chemistry Letters. 19: 6538-43. PMID 19857963 DOI: 10.1016/j.bmcl.2009.10.051  0.44
2009 Chung JY, Hah JM, Cho AE. Correlation between performance of QM/MM docking and simple classification of binding sites. Journal of Chemical Information and Modeling. 49: 2382-7. PMID 19799409 DOI: 10.1021/ci900231p  0.36
2009 Nam BS, Kim H, Oh CH, Lee SH, Cho SJ, Sim TB, Hah JM, Kim DJ, Choi JH, Yoo KH. Aminoquinoline derivatives with antiproliferative activity against melanoma cell line. Bioorganic & Medicinal Chemistry Letters. 19: 3517-20. PMID 19464887 DOI: 10.1016/j.bmcl.2009.05.007  0.44
2009 Chung JY, Cho AE, Hah JM. Hologram and receptor-guided 3D QSAR analysis of anilinobipyridine JNK3 inhibitors Bulletin of the Korean Chemical Society. 30: 2739-2748. DOI: 10.5012/bkcs.2009.30.11.2739  0.36
2008 Li H, Hah JM, Lawrence DS. Light-mediated liberation of enzymatic activity: "small molecule" caged protein equivalents. Journal of the American Chemical Society. 130: 10474-5. PMID 18642802 DOI: 10.1021/ja803395d  0.92
2006 Hah JM, Sharma V, Li H, Lawrence DS. Acquisition of a "Group A"-selective Src kinase inhibitor via a global targeting strategy. Journal of the American Chemical Society. 128: 5996-7. PMID 16669643 DOI: 10.1021/ja060136i  0.92
2004 Flinspach ML, Li H, Jamal J, Yang W, Huang H, Hah JM, Gómez-Vidal JA, Litzinger EA, Silverman RB, Poulos TL. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase. Nature Structural & Molecular Biology. 11: 54-9. PMID 14718923 DOI: 10.1038/nsmb704  0.92
2003 Hah JM, Martásek P, Roman LJ, Silverman RB. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Journal of Medicinal Chemistry. 46: 1661-9. PMID 12699384 DOI: 10.1021/jm0202932  0.92
2001 Hah JM, Roman LJ, Martásek P, Silverman RB. Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N'-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase. Journal of Medicinal Chemistry. 44: 2667-70. PMID 11472219 DOI: 10.1021/jm0101491  0.92
2001 Huang H, Hah JM, Silverman RB. Mechanism of nitric oxide synthase. Evidence that direct hydrogen atom abstraction from the O-H bond of NG-hydroxyarginine is not relevant to the mechanism. Journal of the American Chemical Society. 123: 2674-6. PMID 11456942 DOI: 10.1021/ja005900u  0.92
2000 Hah JM, Roman LJ, Silverman RB. Deuterium isotope effects and product studies for the oxidation of N(omega)-allyl-L-arginine and N(omega)-allyl-N(omega)-hydroxy-L-arginine by neuronal nitric oxide synthase. Bioorganic & Medicinal Chemistry. 8: 1931-6. PMID 11003138 DOI: 10.1016/S0968-0896(00)00154-1  0.92
Show low-probability matches.